BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

2980

539287

ORTINGLOBE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ORTIN GLOBAL LIMITED performance

Today’s low

Today’s high

₹ 10.11 ₹ 11.02
₹ 10.87

52 week low

52 week high

₹ 9.64 ₹ 24.82
₹ 10.87

Open Price

₹ 11.02

Prev. Close

₹ 10.52

Volume (Shares)

5386.00

Total traded value

₹ .58

Upper Circuit

₹ 11.04

Lower Circuit

₹ 9.99

info

ORTIN GLOBAL LIMITED Share Price Update

As of the latest trading session, ORTIN GLOBAL LIMITED share price is currently at ₹ 10.85, which is up by ₹ 0.32 from its previous closing. Today, the stock has fluctuated between ₹ 10.11 and ₹ 11.02. Over the past year, ORTIN GLOBAL LIMITED has achieved a return of -44.96 %. In the last month alone, the return has been 5.63 %. Read More...

ORTIN GLOBAL LIMITED fundamentals


  • Market cap (Cr)

    8.80

  • P/E Ratio (TTM)

    -1.73

  • Beta

    0.65

  • Book Value / share

    2.76

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -0.11

info icon alternate text
  • Market cap (Cr)

    8.40

  • P/E Ratio (TTM)

    -1.73

  • Beta

    0.68

  • Book Value / share

    2.76

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -0.11

info icon alternate text

ORTIN GLOBAL LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 0.03
Operating Expense 0.16
Net Profit -0.11
Net Profit Margin (%) -366.66
Earnings Per Share (EPS) -0.13
EBITDA -0.11
Effective Tax Rate (%) -10.00
Particulars SEP 2024 (Values in Cr)
Revenue 0.05
Operating Expense 0.53
Net Profit -0.47
Net Profit Margin (%) -939.99
Earnings Per Share (EPS) -0.58
EBITDA -0.44
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.21
Operating Expense 0.31
Net Profit -0.10
Net Profit Margin (%) -47.61
Earnings Per Share (EPS) -0.13
EBITDA -0.10
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.14
Operating Expense 3.49
Net Profit -4.14
Net Profit Margin (%) -2957.14
Earnings Per Share (EPS) -5.10
EBITDA -3.05
Effective Tax Rate (%) -30.50
Particulars DEC 2023 (Values in Cr)
Revenue 0.14
Operating Expense 2.94
Net Profit -2.79
Net Profit Margin (%) -1992.85
Earnings Per Share (EPS) -3.43
EBITDA -2.61
Effective Tax Rate (%) 0.71
Particulars MAR 2024 (Values in Cr)
Revenue 2.11
Operating Expense 9.36
Net Profit -8.04
Net Profit Margin (%) -381.04
Earnings Per Share (EPS) -9.89
EBITDA -6.36
Effective Tax Rate (%) -13.70
Particulars MAR 2023 (Values in Cr)
Revenue 6.02
Operating Expense 6.15
Net Profit -0.09
Net Profit Margin (%) -1.49
Earnings Per Share (EPS) -0.12
EBITDA 0.54
Effective Tax Rate (%) 18.18
Particulars MAR 2022 (Values in Cr)
Revenue 8.23
Operating Expense 8.95
Net Profit -0.40
Net Profit Margin (%) -4.86
Earnings Per Share (EPS) -0.49
EBITDA 0.57
Effective Tax Rate (%) 24.52
Particulars MAR 2021 (Values in Cr)
Revenue 8.17
Operating Expense 8.08
Net Profit 0.95
Net Profit Margin (%) 11.62
Earnings Per Share (EPS) 1.16
EBITDA 1.30
Effective Tax Rate (%) -578.57
Particulars MAR 2020 (Values in Cr)
Revenue 197.39
Operating Expense 196.86
Net Profit -0.56
Net Profit Margin (%) -0.28
Earnings Per Share (EPS) -0.33
EBITDA 5.89
Effective Tax Rate (%) 177.77
Particulars MAR 2024 (Values in Cr)
Book Value / Share 3.47
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.60
EBITDA Margin -200.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.36
ROE % -0.64
ROCE % 1.79
Total Debt to Total Equity 0.58
EBITDA Margin 9.30
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.47
ROE % -3.59
ROCE % 1.57
Total Debt to Total Equity 0.59
EBITDA Margin 6.93
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.97
ROE % 5.40
ROCE % 3.19
Total Debt to Total Equity 0.75
EBITDA Margin 15.79
Particulars MAR 2020 (Values in Cr)
Book Value / Share 14.06
ROE % -2.29
ROCE % 8.74
Total Debt to Total Equity 0.80
EBITDA Margin 2.98
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.34
Total Assets 6.66
Total Liabilities 6.66
Total Equity 2.82
Share Outstanding 8131392
Price to Book Ratio 5.13
Return on Assets (%) -120.65
Return on Capital (%) -173.81
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 21.19
Total Liabilities 21.19
Total Equity 10.86
Share Outstanding 8131392
Price to Book Ratio 1.30
Return on Assets (%) -0.44
Return on Capital (%) -0.54
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.59
Total Assets 20.70
Total Liabilities 20.70
Total Equity 10.95
Share Outstanding 8131392
Price to Book Ratio 1.68
Return on Assets (%) -1.92
Return on Capital (%) -2.33
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.17
Total Assets 21.26
Total Liabilities 21.26
Total Equity 11.35
Share Outstanding 8131392
Price to Book Ratio 2.31
Return on Assets (%) 4.44
Return on Capital (%) 5.17
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2.49
Total Assets 116.51
Total Liabilities 116.51
Total Equity 23.81
Share Outstanding 16940400
Price to Book Ratio 0.52
Return on Assets (%) -0.48
Return on Capital (%) -1.3
Particulars MAR 2024 (Values in Cr)
Net Income -7.07
Cash from Operations -3.49
Cash from Investing 12.00
Cash from Financing -3.48
Net change in Cash 3.72
Free Cash Flow -3.49
Particulars MAR 2023 (Values in Cr)
Net Income -0.11
Cash from Operations -0.25
Cash from Investing 0.00
Cash from Financing 0.90
Net change in Cash 0.65
Free Cash Flow -0.25
Particulars MAR 2022 (Values in Cr)
Net Income -0.52
Cash from Operations 2.14
Cash from Investing -0.12
Cash from Financing -0.47
Net change in Cash 1.55
Free Cash Flow 2.27
Particulars MAR 2021 (Values in Cr)
Net Income 0.13
Cash from Operations 18.03
Cash from Investing 0.06
Cash from Financing -9.85
Net change in Cash 8.24
Free Cash Flow 18.03
Particulars MAR 2020 (Values in Cr)
Net Income 0.71
Cash from Operations 4.13
Cash from Investing -3.09
Cash from Financing -1.33
Net change in Cash -1.12
Free Cash Flow 7.25
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2959.45 58.70 29.97 50134.87 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

ORTIN GLOBAL LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
10.87 3.32 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 11.00
  • 26 Days 11.30
  • 10 Days 11.00
  • 50 Days 12.10
  • 12 Days 11.00
  • 100 Days 13.90
  • 20 Days 11.10
  • 200 Days 16.00
10.86 PIVOT

First Support

10.18

First Resistance

11.20

Second Support

9.84

Second Resistance

11.88

Third Support

9.16

Third Resistance

12.22

RSI

45.13

ADX

11.69

MACD

-0.23

Williams % R

-47.78

Commodity Channel Index (CCI)

-42.28

Date

2025-04-08

Week

5905.00

Same Day

8292.00

Month

21923.00

1 Year

0.66

3 Year

0.76

Over 1 Month

5.63%

down

Over 1 Year

-44.96%

down

Over 3 Months

-31.67%

down

Over 3 Years

-25.08%

down

Over 6 Months

-41.65%

down

Over 5 Years

-7.02%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

ORTIN GLOBAL LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
92.23%
Promoter Holdings
1.23%
FII
6.52%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Rajesh Poddar 381467.0 (4.69%) Public Shareholding
Prabha Rameshkumar Gupta 380000.0 (4.67%) Public Shareholding
Wave Capital Ltd 295000.0 (3.63%) Public Shareholding
Beacon Stone Capital Vcc - Beacon Stone I 235728.0 (2.9%) Public Shareholding
Nitin Sharma 101000.0 (1.24%) Public Shareholding
Sanka Tandav Krishna 40512.0 (0.5%) Shareholding of Promoter and Promoter Group
Venkata Sujatha Sanka 21944.0 (0.27%) Shareholding of Promoter and Promoter Group
Lakshmi Sravani Dasari 20000.0 (0.25%) Shareholding of Promoter and Promoter Group
Murali Krishna Murthy Sanka 17844.0 (0.22%) Shareholding of Promoter and Promoter Group
Krishna Karthik Sanka 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sanka Naga Jyothi 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sanka Satya Praveen Kumar 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sanka Ravi Sankar 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sanka Hema Kumari 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Srinivasa Kumar Sanka 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Venkata Subbamma Sanka 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Venkata Ratnamma Sanka 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sanka Sharath Kumar 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Balaji Venkateswarlu Sanka 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

ORTIN GLOBAL LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
24 Sep 2013 0.25 Final 26 Sep 2013 Equity shares
24 Sep 2012 0.5 Final 26 Sep 2012 Equity shares
13 Oct 2011 0.5 Final 15 Oct 2011 Equity shares
23 Sep 2010 0.8 Final 25 Sep 2010 Equity shares
23 Sep 2009 0.8 Final 25 Sep 2009 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
24 Sep 2013 0.25 Final 26 Sep 2013 Equity shares
24 Sep 2012 0.5 Final 26 Sep 2012 Equity shares
13 Oct 2011 0.5 Final 15 Oct 2011 Equity shares
23 Sep 2010 0.8 Final 25 Sep 2010 Equity shares
23 Sep 2009 0.8 Final 25 Sep 2009 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

ORTIN GLOBAL LIMITED Share Price

Ortin Laboratories Limited was incorporated in October, 1986 with a nominal capital of Rs 1 lakh to offer quality Drugs and Medicines to the suffering mankind. The Company is a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines in India. The company is engaged in manufacture of Pharma formulations. They manufacture a range of pharmaceutical formulations of tablets, capsules, syrups, dry powders, and ointments in India. The company is having their manufacturing unit at Medak in Andhra Pradesh, which is equipped with technically modern manufacturing facilities to produce complete range of Pharmaceutical Formulations.

The company offer anti arthritic drugs, antibiotics, chemo therapeutics, analgesics and antipyretics, cardiac and cardio vascular drugs, anti diarroheal drugs, anti depressants, anti hypertensive, anti aids, anti tuberculosis drugs, gynaecological drugs, antibiotics, anti diabetic, antacids anti ulcer drugs, anti allergics, anti-cold, decongestants, antioxidents, vitamins, minerals, anti bacterial drugs, anti emetics, anti helmenthetics, nutritional supplements and protein, and appetizers. They also produce dental, ophthalmology, pediatric, diuretics, dermatology, psychiatry, and ENT drugs.

The company constructed a Factory in a spacious area of 25,000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of tablets capsules syrups dry powders & ointments. During the year 2003-04, the company started their second division of products and marketing in few states.

During the year 2006-07, the company got listed their shares in BSE- Indonext model, which provided a nation-wide trading platform for the investors of the company for their effective participation. They completed the up gradation of factory premises as per Revised Schedule M and started exporting their products to Asian, African countries and Middle East countries.

During the year 2009-10, the company acquired the certification for the registration with National Drug Authority, Uganda wherein the company has got the eligibility to export their products to Uganda.

During the year 2010-11, Vineet Laboratories Pvt Ltd, a private limited company engaged in the manufacturing of Fine Chemicals, Custom synthesis and specialized in making bulk drug intermediates for anti retrovirals and lipid lowering agents, etc was amalgamated with the company. Also, the company was allotted 6.18 acres of land in IDA, Buchinelli, Zaheerabad, Medak Dist., AP by APIIC. The company is planning to construct USFDA and European Standard Bulk Drug manufacturing facility.

In 2010-11, M/s. Vineet Laboratories Private Limited (VLPL) was merged with the Company through the Scheme of Amalgamation, which was made effective from October 01, 2010. In terms of the said Scheme of Amalgamation, the Equity Shareholders of VLPL were entitled 17 Equity Shares of the Company for every 10 Equity Share held in Vineet Laboratories Private Limited. Thus, 1,22,40,000 fully paid-up equity shares of Rs. 10/- each of the Company were issued and allotted to the equity shareholders of Vineet Laboratories Private Limited in the same proportion as to their shareholding in Vineet Laboratories Private Limited.

In 2017-18, the scheme of arrangement between the Company and Vineet Laboratories Limited for demerger of the API Intermediates Division of the Company as a going concern was implemented.

Parent organization Indian Private
NSE symbol ORTINGLOBE
Founded 1986
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Ortin Global Ltd?

Answer Field

The share price of Ortin Global Ltd for NSE is ₹ 10.85 and for BSE is ₹ 10.79.

What is the Market Cap of Ortin Global Ltd?

Answer Field

The market cap of Ortin Global Ltd for NSE is ₹ 8.80 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Ortin Global Ltd?

Answer Field

The 52 Week High and Low of Ortin Global Ltd for NSE is ₹ 24.82 and ₹ 9.64 and for BSE is ₹ 24.96 and ₹ 9.57.

How to Buy Ortin Global Ltd share?

Answer Field

You can trade in Ortin Global Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Ortin Global Ltd?

Answer Field

The 1 year returns on the stock has been -44.96%.

What is the Current Share Price of Ortin Global Ltd?

Answer Field

Ortin Global Ltd share price is for NSE ₹ 10.85 & for BSE ₹ 10.79 as on Apr 30 2025 03:29 PM.

What is the Market Cap of Ortin Global Ltd Share?

Answer Field

The market cap of Ortin Global Ltd for NSE ₹ 8.80 & for BSE ₹ 0.0 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of Ortin Global Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Ortin Global Ltd share is -1.73.

What is the PB ratio of Ortin Global Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Ortin Global Ltd share is 2.76.

How to Buy Ortin Global Ltd Share?

Answer Field

You can trade in Ortin Global Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Ortin Global Ltd Share on Bajaj Broking App?

Answer Field

To buy Ortin Global Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Ortin Global Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|